跳至主要内容
临床试验/NCT04745013
NCT04745013招募中不适用

A Multi-center, Investigator-blinded, Randomized, 12-month, Parallel-group, Study to Compare the Clinical and Cost Efficacy of a New Hybrid Exercise Intervention PRIORITY Versus Usual Care

KU Leuven3 个研究点 分布在 1 个国家目标入组 312 人开始时间: 2021年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
KU Leuven
入组人数
312
试验地点
3
主要终点
Changes in cardiorespiratory fitness

研究概览

简要总结

In the PRIORITY study, we aim to provide the clinical evidence base for the use of a new hybrid exercise intervention, which includes remotely guided home-based exercise, as an accessible, clinical and cost-effective treatment to prevent the deleterious effects of sedentary aging on the heart and forestall the development and progression towards overt HFpEF.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
30 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women (HF stage A) aged > 30 yrs:
  • treated or untreated patients with hypertension (blood pressure 130/80 - 159/99 mmHg) AND/OR
  • Patients with prediabetes (impaired fasting glucose and/or insulin resistance) with either:
  • Fasting plasma glucose: 100 to 125 mg/dL (5.6-6.9 mmol/L) Hemoglobine A1c: 5.7% to 6.4% Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) index above 75% of population distribution (>2.0) AND/OR
  • Patients with obesity with 30 kg/m² ≥ body mass index ≤ 42 kg/m²
  • Patients with subclinical signs of diastolic dysfunction without symptoms (HF Stage B disease)
  • Men and women with diagnosis of HF stage C: i.e. patients who have a total score ≥ 5 points according to the recent recommendation paper on how to diagnose heart failure with preserved ejection fraction from the Heart failure Association of ESC.
  • All participants should be on optimal medical treatment and stable with regard to symptoms and pharmacotherapy for at least 4 weeks before enrollment in the study. All participants should have internet access at home.

排除标准

  • significant illness during the last 6 weeks
  • known severe ventricular arrhythmia with functional or prognostic significance
  • significant myocardial ischemia, hemodynamic deterioration or exercise-induced arrhythmia at baseline testing
  • co-morbidity that may significantly negatively influence one-year prognosis
  • functional or mental disability that may limit execution of prescribed exercise
  • severe chronic obstructive pulmonary disease (FEV1 < 50%)
  • NYHA class IV
  • participation in another clinical interventional trial
  • cognitive limitation

结局指标

主要结局

Changes in cardiorespiratory fitness

时间窗: 1- and 2-year follow-up

Changes in cardiorespiratory fitness measured as pVO2 during a CPET until exhaustion

次要结局

未报告次要终点

研究者

发起方
KU Leuven
申办方类型
Other
责任方
Principal Investigator
主要研究者

Véronique Cornelissen

Professor

KU Leuven

研究点 (3)

Loading locations...

相似试验